A Chinese biotechnology facility has achieved a revolutionary breakthrough in pharmaceutical manufacturing by accelerating cancer drug production by a factor of 1,000. This achievement represents a major advancement in fermentation technology and demonstrates how interdisciplinary innovation—combining plant biochemistry, synthetic biology, and protein engineering—can fundamentally transform drug manufacturing efficiency. The development has significant implications for reducing production timelines and potentially lowering costs for oncological treatments.

Summary auto-generated by AI from the original publisher's content. Editorial standards.